GlassScriptPhysician profile
Denise K Thompson
NPI 1457381832
$3,862.78
in general payments reported to CMS, 2019-2025
34 companies · $651 in 2025
The $651 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $483 · 2021: $1,077 · 2022: $811 · 2023: $367 · 2024: $296 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,052.90 | 2019-2025 | Lo Loestrin Fe, Vraylar, Orilissa |
| Novo Nordisk INC | $542.30 | 2019-2025 | Wegovy, Ozempic |
| Exeltis, USA INC. | $376.18 | 2020-2024 | Slynd |
| Therapeuticsmd, INC. | $327.55 | 2019-2022 | |
| Astellas Pharma US INC | $209.79 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $169.52 | 2021-2025 | |
| Amgen INC. | $140.64 | 2020-2025 | Evenity, Prolia |
| Avion Pharmaceuticals | $130.57 | 2019-2023 | Balcoltra |
| Lilly USA, LLC | $98.07 | 2020-2024 | Zepbound, Jardiance |
| Millicent US INC | $77.65 | 2024-2025 | Femlyv, Intrarosa |
| Glaxosmithkline, LLC. | $62.04 | 2020-2023 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $61.12 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.00 | 2021-2022 | |
| Eisai INC. | $56.18 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.58 | 2019-2023 | Xifaxan |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $44.77 | 2021 | |
| Currax Pharmaceuticals LLC | $41.48 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.01 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $35.46 | 2021 | |
| Jazz Pharmaceuticals INC. | $31.76 | 2021 | |
| Hologic Sales and Service, LLC | $30.54 | 2022 | |
| Alfasigma USA, INC. | $27.36 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.38 | 2021-2022 | |
| Sanofi Pasteur INC. | $26.35 | 2019-2022 | |
| Allergan, INC. | $18.91 | 2020 | |
| Baxter Healthcare | $18.63 | 2022 | |
| Esperion Therapeutics, INC. | $16.19 | 2021 | |
| Tactile Systems Technology INC | $15.83 | 2024 | Flexitouch Plus, Entre Plus |
| Cosette Pharmaceuticals INC. | $14.80 | 2025 | Vyleesi |
| Duchesnay USA Incorporated | $14.40 | 2019 | |
| Exact Sciences Corporation | $14.01 | 2025 | The Cologuard Plus Collection Kit |
| Abbott Laboratories | $12.98 | 2022 | |
| Lupin INC. | $12.74 | 2019 | |
| Medtronic, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.